Baillie Gifford Global Discovery B Acc
GlobalPricing frequency
Daily
Dealing cut off time
08:45
Type
OEIC
Yield
–
NAV
1,602.00p
Income frequency
Annually
Ongoing charge
0.78%
Latest actual NAV date
13-10-2026
ISIN
GB0006059330
UCITS
Yes
This fund can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment
Before investing please read:
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/08/2026 | % of assets |
|---|---|
| Twist Bioscience Corp | 5.86 |
| Axon Enterprise Inc | 4.59 |
| Xometry Inc Ordinary Shares - Class A | 4.55 |
| Alnylam Pharmaceuticals Inc | 4.13 |
| Aspeed Technology Inc | 3.66 |
| Oxford Nanopore Technologies PLC | 3.36 |
| Astera Labs Inc | 3.24 |
| MercadoLibre Inc | 3.20 |
| Guardant Health Inc | 2.91 |
| JFrog Ltd Ordinary Shares | 2.78 |
Investment objective
The Sub-fund aims to outperform (after deduction of costs) the S&P Global Small Cap Index, as stated in sterling, over rolling five-year periods. The Sub-fund will invest at least 90% in shares of companies. The Sub-fund will be actively managed and will invest in shares of companies in any country and in any sector which typically at the time of initial purchase have a market capitalisation which is smaller than or equal to the market capitalisation of the largest company in the S&P Global Small Cap Index (measured on the second business day of each calendar month) and that the Investment Adviser considers will offer excellent future growth prospects.